T. Rowe Price Associates’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,182
| Closed | -$22K | – | 3069 |
|
|
2025
Q1 | $22K | Hold |
14,182
| – | – | ﹤0.01% | 2997 |
|
|
2024
Q4 | $31K | Sell |
14,182
-365,762
| -96% | -$800K | ﹤0.01% | 2966 |
|
|
2024
Q3 | $1.65M | Sell |
379,944
-433,122
| -53% | -$1.89M | ﹤0.01% | 1727 |
|
|
2024
Q2 | $3.79M | Buy |
+813,066
| New | +$3.79M | ﹤0.01% | 1305 |
|
|
2020
Q4 | – | Sell |
-27,028
| Closed | -$817K | – | 2669 |
|
|
2020
Q3 | $817K | Buy |
+27,028
| New | +$817K | ﹤0.01% | 1895 |
|